XML 19 R27.htm IDEA: XBRL DOCUMENT v2.3.0.15
Concentration of Business Risk (Details) (USD $)
3 Months Ended9 Months Ended3 Months Ended9 Months Ended3 Months Ended9 Months Ended9 Months Ended12 Months Ended
Sep. 30, 2011
Dec. 31, 2010
Sep. 30, 2011
Partner A
Sep. 30, 2010
Partner A
Sep. 30, 2011
Partner A
Sep. 30, 2010
Partner A
Sep. 30, 2011
Partner B
Sep. 30, 2010
Partner B
Sep. 30, 2011
Partner B
Sep. 30, 2010
Partner B
Sep. 30, 2011
Partner C
Sep. 30, 2010
Partner C
Sep. 30, 2011
Partner C
Sep. 30, 2010
Partner C
Sep. 30, 2011
Regulus Therapeutics Inc.
Contract receivables
Dec. 31, 2010
Regulus Therapeutics Inc.
Contract receivables
Sep. 30, 2011
Contract receivables
person
Dec. 31, 2010
Contract receivables
person
Sep. 30, 2011
Contract receivables, Significant Partner One
Dec. 31, 2010
Contract receivables, Significant Partner One
Dec. 31, 2010
Contract receivables, Significant Partner Two
Concentration of business risk                     
Significant partner, defined (more than, as a percent)10.00%                    
Significant partners, percent (as a percent)  80.00%59.00%75.00%61.00%10.00%24.00%16.00%10.00%3.00%2.00%3.00%14.00%       
Number of significant partners                12   
Percentage of contract receivable from significant partner (as a percent)              35.00%44.00%  54.00%30.00%15.00%
Contract receivable (in dollars)$ 1,858,000$ 1,242,000            $ 646,000$ 544,000